154 related articles for article (PubMed ID: 25754535)
1. Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications.
Liao YJ; Fang CC; Yen CH; Hsu SM; Wang CK; Huang SF; Liang YC; Lin YY; Chu YT; Arthur Chen YM
Int J Cancer; 2015 Sep; 137(6):1341-51. PubMed ID: 25754535
[TBL] [Abstract][Full Text] [Related]
2. Secretory NPC2 Protein-Mediated Free Cholesterol Levels Were Correlated with the Sorafenib Response in Hepatocellular Carcinoma.
Suk FM; Wang YH; Chiu WC; Liu CF; Wu CY; Chen TL; Liao YJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445279
[TBL] [Abstract][Full Text] [Related]
3. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
Twu YC; Lee TS; Lin YL; Hsu SM; Wang YH; Liao CY; Wang CK; Liang YC; Liao YJ
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420058
[TBL] [Abstract][Full Text] [Related]
4. Niemann-Pick Type C2 Protein Regulates Free Cholesterol Accumulation and Influences Hepatic Stellate Cell Proliferation and Mitochondrial Respiration Function.
Wang YH; Twu YC; Wang CK; Lin FZ; Lee CY; Liao YJ
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874879
[TBL] [Abstract][Full Text] [Related]
5. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Niemann-Pick Type C2 protein expression in multiple cancers using a novel NPC2 monoclonal antibody.
Liao YJ; Lin MW; Yen CH; Lin YT; Wang CK; Huang SF; Chen KH; Yang CP; Chen TL; Hou MF; Arthur Chen YM
PLoS One; 2013; 8(10):e77586. PubMed ID: 24147030
[TBL] [Abstract][Full Text] [Related]
7. Novel function of Niemann-Pick C1-like 1 as a negative regulator of Niemann-Pick C2 protein.
Yamanashi Y; Takada T; Shoda J; Suzuki H
Hepatology; 2012 Mar; 55(3):953-64. PubMed ID: 22095670
[TBL] [Abstract][Full Text] [Related]
8. Ribose-5-phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling.
Ciou SC; Chou YT; Liu YL; Nieh YC; Lu JW; Huang SF; Chou YT; Cheng LH; Lo JF; Chen MJ; Yang MC; Yuh CH; Wang HD
Int J Cancer; 2015 Jul; 137(1):104-15. PubMed ID: 25429733
[TBL] [Abstract][Full Text] [Related]
9. Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway.
Wu Y; Liu H; Weng H; Zhang X; Li P; Fan CL; Li B; Dong PL; Li L; Dooley S; Ding HG
Int J Oncol; 2015 Mar; 46(3):1275-85. PubMed ID: 25572615
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Talin1 promotes hepatocellular carcinoma progression through activation of the ERK1/2 pathway.
Chen P; Lei L; Wang J; Zou X; Zhang D; Deng L; Wu D
Cancer Sci; 2017 Jun; 108(6):1157-1168. PubMed ID: 28375585
[TBL] [Abstract][Full Text] [Related]
11. Glycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis.
Liao YJ; Chen TL; Lee TS; Wang HA; Wang CK; Liao LY; Liu RS; Huang SF; Chen YM
Mol Med; 2012 May; 18(1):412-22. PubMed ID: 22183894
[TBL] [Abstract][Full Text] [Related]
12. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
[TBL] [Abstract][Full Text] [Related]
13. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
[TBL] [Abstract][Full Text] [Related]
14. Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.
Guo Y; Peng Y; Gao D; Zhang M; Yang W; Linghu E; Herman JG; Fuks F; Dong G; Guo M
Clin Epigenetics; 2017; 9():116. PubMed ID: 29075359
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.
Zheng D; Hu Z; He F; Gao C; Xu L; Zou H; Wu Z; Jiang X; Wang J
Oncol Rep; 2014 Jul; 32(1):411-8. PubMed ID: 24807674
[TBL] [Abstract][Full Text] [Related]
16. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
[TBL] [Abstract][Full Text] [Related]
17. Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway.
Takeishi K; Taketomi A; Shirabe K; Toshima T; Motomura T; Ikegami T; Yoshizumi T; Sakane F; Maehara Y
J Hepatol; 2012 Jul; 57(1):77-83. PubMed ID: 22425622
[TBL] [Abstract][Full Text] [Related]
18. PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma.
Jiang H; Zhu Y; Zhou Z; Xu J; Jin S; Xu K; Zhang H; Sun Q; Wang J; Xu J
Cancer Med; 2018 Mar; 7(3):869-882. PubMed ID: 29441724
[TBL] [Abstract][Full Text] [Related]
19. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
[TBL] [Abstract][Full Text] [Related]
20. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
Gu W; Li X; Wang J
Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
